Much of the biopharmaceutical industry this week is focused on the J.P. Morgan Healthcare Conference (JPM), where business leaders are investing in science and technologies with the potential to ...
There are shortcomings in the ways we have approached value assessment to date, writes the executive director of the Innovation and Value Initiative. Jennifer Bright is the executive director of the ...
As America’s healthcare system continues to evolve, it is critical that our perception of care and its value to patients evolve with it. In the past, value assessments have marginalized patients’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results